about
Trial watch - inhibiting PARP enzymes for anticancer therapyDetection and delineation of oral cancer with a PARP1 targeted optical imaging agent.Initial evaluation of Cu-64 labeled PARPi-DOTA PET imaging in mice with mesothelioma.Imaging the DNA damage response with PET and SPECTStrategies for the Use of Poly(adenosine diphosphate ribose) Polymerase (PARP) Inhibitors in Cancer Therapy.Crystal structure-based discovery of a novel synthesized PARP1 inhibitor (OL-1) with apoptosis-inducing mechanisms in triple-negative breast cancer.PARP-1 overexpression contributes to Cadmium-induced death in rat proximal tubular cells via parthanatos and the MAPK signalling pathwayPARPi-FL--a fluorescent PARP1 inhibitor for glioblastoma imagingRadioiodinated PARP1 tracers for glioblastoma imaging.Optical Imaging of PARP1 in Response to Radiation in Oral Squamous Cell Carcinoma.Expression of DNA Damage Response Molecules PARP1, γH2AX, BRCA1, and BRCA2 Predicts Poor Survival of Breast Carcinoma Patients.Individual and Combined Expression of DNA Damage Response Molecules PARP1, γH2AX, BRCA1, and BRCA2 Predict Shorter Survival of Soft Tissue Sarcoma Patients.Dual-Modality Optical/PET Imaging of PARP1 in GlioblastomaPARP1 Inhibitors: antitumor drug design.On the future contents of a small journal of histochemistry.Non-invasive PET Imaging of PARP1 Expression in Glioblastoma Models.Fluorescent-Guided Surgical Resection of Glioma with Targeted Molecular Imaging Agents: A Literature Review.The Effect of Poly(ADP-ribose) Polymerase-1 Gene 3'Untranslated Region Polymorphism in Colorectal Cancer Risk among Saudi Cohort.Nicotinamide phosphoribosyltransferase in malignancy: a review.Correlation between PARP-1 immunoreactivity and cytomorphological features of parthanatos, a specific cellular death in breast cancer cells.Targeted therapy in gliomas.PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma.The Process and Regulatory Components of Inflammation in Brain Oncogenesis.Impact of Histochemistry on biomedical research: looking through the articles published in a long-established histochemical journal.Poly (ADP-ribose) polymerase 1 protein expression in normal and neoplastic prostatic tissue.Histochemistry as an irreplaceable approach for investigating functional cytology and histology.Poly-(ADP-ribose)-polymerase inhibitors as radiosensitizers: a systematic review of pre-clinical and clinical human studies.The dual role of poly(ADP-ribose) polymerase-1 in modulating parthanatos and autophagy under oxidative stress in rat cochlear marginal cells of the stria vascularis.PARP1 in Carcinomas and PARP1 Inhibitors as Antineoplastic Drugs.An analysis of the gene interaction networks identifying the role of PARP1 in metastasis of non-small cell lung cancer.Measurement of drug-target engagement in live cells by two-photon fluorescence anisotropy imaging.Biomarker-Based PET Imaging of Diffuse Intrinsic Pontine Glioma in Mouse Models.JNK Activation Contributes to Oxidative Stress-Induced Parthanatos in Glioma Cells via Increase of Intracellular ROS Production.PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed glioblastoma, with treatment stratified by MGMT status.The PARP inhibitor olaparib potentiates the effect of the DNA damaging agent doxorubicin in osteosarcoma.The p53 Pathway in Glioblastoma
P2860
Q26745673-7055DD4E-28DC-4E81-AE0F-D7096279064EQ27347956-DDAF303B-6B19-4723-93EB-FF99529F66C2Q30252194-F7BA2F5D-0E34-4D52-B620-F649CDECF602Q33581909-DDCFA602-A9BC-4F69-86F2-7CEF041DE9EDQ33649555-31967D73-2769-4F4F-917D-F9B579284D83Q33685138-07F5ECBB-F9E0-487F-B239-0F14134E0BFEQ33849064-D5C9BABD-C5E8-443F-A058-28EE5F73CC36Q34346449-5933D3C9-18AC-47ED-8989-C7812B53ED4BQ35764111-569B15C1-4B65-440D-A6BC-D953A6090ABAQ35903928-4AF8AECC-9A73-448D-BD4C-33F3AC949E09Q36038008-65D52811-674D-4440-80AF-DB70DDA71190Q36137287-89985765-F163-4C73-BF34-E1199E1287ACQ36172457-CF207AC6-F51C-4FFB-A5E2-CCEA193CAC05Q36175159-4CE8B2DB-7E7D-4323-95C6-04977E3F5867Q36596583-B8419C3F-FBB3-463E-BCA6-293E34E96648Q36827491-3E3C2DD6-5FE5-4753-8B2D-F965AA0480CCQ37026387-9E67187B-AF8B-4982-804B-6BE674B2A939Q37322627-AE677168-8375-400D-8973-31CD35E56D8DQ37424391-04A67427-6A95-4988-9F6D-4DA5B4C915DBQ37494636-852EDE22-8316-4E04-A177-6426B2C1B0E6Q38186656-0F231A53-1404-46A8-8779-A60D58AA9663Q38707021-4D1A584E-6184-48B6-9DD7-B4E01666410EQ39202332-9AB5F2C1-BB4E-4103-8C1B-2BE646AB5833Q41595424-0558B14E-0AD1-4641-B14C-13963B4BAA82Q41766110-6F55EDAA-4C04-4113-9588-014D7A83B125Q41836330-D56C0868-D621-488B-A083-065F1C13AA69Q42083096-04FBA878-36AC-4CC1-95E0-13A24B8A8AE3Q42378078-504812BD-1AB7-4E00-8844-868F472FA1AFQ43042008-37FC0AC4-0566-45C4-86B6-66FE1FA1577DQ44000570-A9FA53BD-D82A-4016-A39D-B9CA98A938A9Q47949142-CEF7E684-AC4A-459C-B71F-3E397675D375Q48347188-2496C854-3826-48F8-AC89-57A6502209DEQ48735294-6052A682-69E9-4CDD-95D1-04719DF129E7Q52802452-F28BB6AD-D270-4789-AEBD-D0F6E733469CQ55037005-D676FBE4-EC55-4E36-B5FC-959036EA778AQ57162865-C6E7B348-E5A3-4E09-AA17-2E4CFC50ACC0
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
PARP-1 protein expression in glioblastoma multiforme.
@ast
PARP-1 protein expression in glioblastoma multiforme.
@en
type
label
PARP-1 protein expression in glioblastoma multiforme.
@ast
PARP-1 protein expression in glioblastoma multiforme.
@en
prefLabel
PARP-1 protein expression in glioblastoma multiforme.
@ast
PARP-1 protein expression in glioblastoma multiforme.
@en
P2093
P2860
P356
P1476
PARP-1 protein expression in glioblastoma multiforme.
@en
P2093
A E Calogero
A La Corte
F Fraggetta
R Castiglione
R Condorelli
P2860
P356
10.4081/EJH.2012.E9
P577
2012-02-27T00:00:00Z